Host genetics plays an important role in determining the outcome of Mycobacterium tuberculosis (Mtb) 18 infection. We previously found that Collaborative Cross mouse strains differ in their susceptibility to 19
derived from a CC001/Unc (CC001) x CC042 intercross, we mapped four QTL underlying 23
Tuberculosis ImmunoPhenotypes (Tip1-4). These included 2 major effect QTL on Chromosome 7 24 (Tip1 and Tip2) that were associated with bacterial burden. Tip2, along with Tip3 (Chromosome 15) 25
and Tip4 (Chromosome 16) also correlated with IFNg production following infection, whereas Tip1 26 appeared to control an IFNg-independent mechanism of bacterial control. Further immunological 27 characterization revealed that CC042 animals recruited relatively few antigen-specific T cells to the 28 lung and these T cells failed to express the Integrin alpha L (αL; i.e., CD11a), which contributes to T 29 cell activation and migration. These defects could be explained by a CC042 private variant in the 30
Itgal gene, which encodes CD11a, and is found within the Tip2 interval. This 15bp deletion leads to 31 aberrant mRNA splicing and is predicted to result in a truncated protein product. The Itgal CC042 32 genotype was associated with all measured disease traits, indicating that this variant is a major 33 determinant of susceptibility in CC042. The combined effect of functionally distinct Tip variants 34 likely explains the profound susceptibility of CC042 and highlights the multigenic nature of TB 35 control in the Collaborative Cross. Nearly one quarter of the world's population has been exposed to Mycobacterium tuberculosis (Mtb), yet 51 less than 10% of these exposures progress to clinical disease (1). The rational design of more 52 effective interventions requires understanding the factors that determine the outcome this 53 interaction. A large body of evidence supports an important role for host genetics in determining 54 disease progression, including classic twin studies (2, 3), linkage analyses (4-8), and both case-control 55 (9, 10) and genome-wide association studies (11, 12) . However, the genetic variants that determine 56 the risk of adult pulmonary disease remain elusive due both to the complexity of factors influencing 57 clinical outcome and the lack of model systems that reflect the diversity of natural populations. 58 59 Much of the mechanistic insight into protective immunity against Mtb comes from mouse models of 60 infection. Resistant strains of mice, such as the commonly used C57BL/6J (B6), are able to restrict 61 the replication of Mtb for over a year (13) . Protective immunity in B6 mice relies heavily on Th1 62 biased CD4+ T cell activation and the production of IFNg in the infected tissue (14, 15) . IFNg 63 mediates its protective effect both by activating microbiocidal mechanisms in parasitized 64 macrophages (16) (17) (18) and by inhibiting the recruitment of granulocytes that have been shown to 65 exacerbate disease (19, 20) . As these effects require local production of cytokine, the adhesion 66 molecules and chemokines required for T cell recruitment play a pivotal role in immunity. Studies in 67 knockout mice have shown that T cell expression of the integrin aLb2 and the chemokine receptors 68 CXCR3, CCR5, and CCR2 are important for the proper positioning of these T cells and the 69 expression of protective immunity in the lung (21) (22) (23) (24) . 70
71
Despite the wealth of mechanistic data that can be obtained in the mouse model, standard lab strains 72 of mice do not reproduce the diversity in pathogenesis observed in natural populations. Not only 73 does the relatively homogenous histopathology observed in these animals differ from the variable 74 disease seen in patients (21), but recent evidence suggests an unappreciated diversity in human 75 immune responses to Mtb (22) . For example, it now appears that some humans have the capacity to 76 control Mtb infection in the absence of the IFNg response that is critical in B6 mice (23), and 77 emerging evidence also suggests a possible protective role for antibodies that play little role in the 78 standard mouse model (24, 25) . Much of the previous work to increase the diversity of TB disease 79 in mice has focused on relatively susceptible sub-strains that remain closely related to B6 mice (26). 80
While studies contrasting these strains have identified a number of quantitative trait loci (QTL) 81 associated with susceptibility (27-32), these highly-related strains still do not mimic the diversity 82 observed in an outbred population. 83
84
Recently, a number of new resources have become available to introduce additional genetic 85 variability into mouse model systems. For example, Diversity Outbred (DO) mice are an outbred 86 population of genetic mosaics based on eight inbred founders, including highly divergent wild-87 derived strains (33). Mtb infection of DO mice produces a wide-range of disease manifestations 88 including extreme susceptibility, which is not observed in more standard lab strains (34). While the 89 DO population incorporates a great deal of diversity, each genotype is represented by a single 90 unique mouse, limiting the mechanistic characterization that is otherwise a strength of the mouse 91 system. The Collaborative Cross (CC) consists of recombinant inbred lines derived from the same 92 eight inbred founder strains as the DO (35) . In contrast to the outbred DO, each CC strain 93 represents a reproducible mosaic of the founder genomes, and thus a reproducible model of disease 94 (36). We have shown that the range TB susceptibility observed in the DO population can be 95 recapitulated in CC mice (37). This previous work found that CC042/GeniUnc (CC042) animals 96 was highly susceptible to Mtb infection, in contrast to resistant strains such as CC001/Unc or B6 97 (37). 98
99
Here we investigated the basis TB susceptibility in the CC042 strain using a parallel genetic and 100 immunophenotyping approach. By producing an intercross population based on CC042 and the 101 resistant CC001 strains, we identified multiple QTL, named "Tuberculosis ImmunoPhenotype" 102 (Tip1-4), that were differentially associated with bacterial burden and/or IFNg production. In this 103 population, canonical IFNg -dependent immunity was controlled by a novel mutation in the Itgal 104 gene, which disrupts expression of the aLb2 adhesion molecule and prevents the recruitment of 105 cytokine expressing T cells to the site of infection. Other Tip loci were driven by wild-derived 106 founder alleles that either reduce IFNg production or control IFNg -independent immunity. 107
Together, these observations explain the extreme susceptibility of CC042 and indicate that the CC 108 panel can be used to understand diverse mechanisms of protective immunity to Mtb. 109 110
Results: 111

Control of Mtb infection in CC042 is lost upon the onset of adaptive immunity. 112
In order to dissect the mechanisms underlying CC042 susceptibility to Mtb, we first profiled the 113 kinetics of disease in aerosol-infected CC042 animals compared to more resistant B6 mice. In the 114 standard B6 model, the peak of bacterial burden was observed around 21 days post infection, 115 coincident with the onset of robust Th1 immunity. While CC042 had 10-fold lower CFU in the 116 lung and spleen at 14 days, compared to B6 (Fig1A, B) , CC042 animals ultimately failed to control 117 bacterial replication. By day 28 post-infection, the lungs of CC042 mice harbored 100-fold more 118 bacteria compared to B6. Similar trends in relative bacterial burden were observed in the spleen. All was apparent in CC042 lungs by 21 days, and was sustained until termination of the experiment (28 130 -33 days post infection) ( Fig 2) . Together, these data suggested that the susceptibility of CC042 131 could be related to a defect in IFNg production that promoted bacterial growth and granlulocyte 132 infiltration. 133 134
Identifying TB susceptibility loci in a [CC001xCC042] intercross 135
To investigate the genetic basis of CC042 susceptibility, we took an F2 intercross approach to 136 segregate TB disease traits and map the causal genetic variants. CC001 was chosen as the CC cross 137 partner because of its relative TB resistance (similar to a B6) (37) and to match the CC042 H-2 b 138 locus. We crossed female CC001 with male CC042 mice to generate F1 progeny (CC001xCC042)F1, 139 which were then intercrossed to produce ~200 F2 offspring. We infected male and female F1 and F2 140 progeny, along with parental strains, with Mtb (H37Rv) via low-dose aerosol. Mice were sacrificed 141 between 28-31 days post-infection, a timepoint that maximized phenotypic differences, while 142 minimizing morbidity. Measured phenotypes included lung colony forming units (CFU), spleen 143 CFU, and lung IFNg levels. 144
145
For spleen CFU and lung IFNg levels, F1 mice showed an intermediate phenotype, and F2 mice 146 displayed a distribution of values spanning the range of the parental strains ( Fig 3A, B) . In contrast, 147 overdominance was observed for lung CFU, as F1 mice had higher bacterial burdens in the lung than 148 the susceptible CC042 mice ( Fig 3C) and F2 mice spanned this greater phenotypic range. The three 149 traits co-varied in a predictable manner ( Fig 3D) . Bacterial burden in lung and spleen were 150 positively correlated. Lung IFNg levels were more strongly associated with CFU in spleen than 151 lung, consistent with the more prominent role of IFNg-independent T cell functions in the lung 152 (38). The imperfect correlation between these traits, as well as the expansion of phenotypic ranges 153 in F2 animals, suggested that multiple genes controlled the differences between CC001 and CC042. 154
155
In total, 169 F2 mice were genotyped with the MiniMUGA array (39). We first validated our genetic 156 mapping protocol using a coat color trait (Supp Fig 1) . CC042 have a white head spot ("blaze") on 157 their forehead, a characteristic inherited from the WSB/EiJ (designated for Watkins Star Blaze; 158 WSB) founder strain. One in every four F2 progeny carried a blaze, confirming autosomal recessive 159 inheritance (40). The blaze and base coat color (black from CC001 or agouti from CC042) assorted 160 independently in the F2 offspring, as shown by the expected 9:3:3:1 ratio (Supp Fig 1) . QTL 161 mapping on the presence or absence of white head spotting in the F2 mice identified a highly 162 significant QTL on Chromosome 10 (Supp Fig 1) . This interval contained kit ligand (Kitl, stem cell 163 factor), which was previously shown to underly this trait in the pre-CC population (40). 164 165 Next, we conducted QTL mapping on the tuberculosis-associated phenotypes Lung CFU, Spleen 166 CFU and IFNg levels. Using batch and sex as covariates, we identified four significant QTL that 167 affect measured Tuberculosis ImmunoPhenotypes (Tip1-4) ( Table 1 and Figure 4A Spleen CFU mapped to two distinct QTL on Chromosome 7; proximal Tip1 at 72Mb and distal Tip2 177 at 125Mb ( Figure 4C ). Tip1 was inherited in an additive fashion, with heterozygous mice carrying 178 both CAST/EiJ (CAST) and WSB haplotypes exhibiting an intermediate phenotype relative to both 179 homozygotes ( Fig 4F) . In contrast, the susceptibility phenotype associated with Tip2 was recessive, 180 with mice homozygous for the WSB allele demonstrating a tenfold increase in spleen CFU on 181 average ( Fig 4G) . IFNg production in the lung was associated with 3 distinct QTL. The main locus 182 explained 21.4% of the variation and was mapped to the Tip2 region on chromosome 7 ( Fig 4B) , 183 evidence that the same variant likely controls IFNg and bacterial burden at this locus. Two 184 additional QTL were also associated with IFNg levels, mapping to Chromosomes 15 and 16 (Tip3 185 and Tip4 respectively) ( Fig 4A and B) . A second potential QTL on proximal Chromosome 16 was 186 also associated with IFNg, however its LOD did not reach genome wide significance at P<0.05. At 187
Tip3, low IFNg levels were associated with haplotypes from the CAST (Fig 4D) founder, a strain 188 previously found to lack IFNg expression in the lung upon infection with either Mtb or pox virus 189 (37, 41, 42) . Notably, Tip1 was associated with CFU, but not IFNg, indicating that this variant was 190 functionally distinct from Tip2. No QTL were associated with lung CFU, suggesting that this trait is 191 under more complex genetic control than the others. In sum, these functionally and genetically 192 diverse QTL indicated that the immune response to Mtb was under multigenic control in these 193
strains. 194 195
Considering that Tip1 and Tip2 are both on Chromosome 7 and are driven by the WSB parent 196 haplotype, we tested the independence of these peaks by remapping spleen CFU using the 197 genotypes at Tip1as a covariate. After removing the variation explained by the proximal Tip1 QTL, 198 the distal Tip2 QTL still met the threshold for genome-wide significance (Supp Fig 2A) . In addition, 199
fitting a three QTL model to the spleen CFU phenotypes showed that Tip1, Tip2, and Tip3 all 200 contributed additively; removing any of them from the full model resulted in a significantly poorer 201 fit (Supp Fig 2B) . Altogether, we identified four independent QTL in the F2 cross, indicating 202 multigenic control of Mtb immunity in this F2 population. 203 204 T cell function and recruitment are impaired in CC042 mice 205
Concurrent with our genetic mapping strategy, we enumerated changes in leukocyte cell types that 206 could alter the susceptibility of CC042 relative to B6 mice. Accumulation of T and B lymphocytes in 207 the lungs of B6 mice began between 14 and 21 days post-infection ( Fig 5A, B) . In contrast, the 208 numbers of T and B cells in the lungs of CC042 mice were significantly reduced. This paucity of 209 lymphocyte accumulation in the lungs of CC042 mice was mirrored a dramatic increase in 210 CD11b+Gr1+ granulocytes ( Fig 5C) , consistent with the neutrophilic infiltrates observed in the 211 lung histopathology (Figure 2 ). Significant differences in the CD11b+Gr1-monocytes/macrophage 212 subset between these mice was only apparent at the last timepoint, at which time the CC042 animals 213 had become moribund ( Fig 5D) . 214
215
The reduction in IFNg production and paucity of pulmonary T cells in the lungs of CC042 mice 216 suggested that their susceptibility to Mtb might be related to a defect in T cell function. To assess 217 effector function, we isolated cells from the lungs of infected B6 and CC042 mice and stimulated 218 them with anti-CD3 to determine whether T cells from CC042 mice had differentiated into a distinct 219 T cell subset (e.g. Th1 vs. Th2, Th17, Treg). Using a standard intracellular cytokine staining (ICS) 220 approach, we found that CD4 and CD8 T cells from CC042 mice produced less IFNg, TNF, IL-17a, 221 IL-2, IL-10 and CD107a upon stimulation in comparison to B6 T cells ( Fig 6A, B) . Thus, instead of 222
representing an altered T cell differentiation state, the lack of cytokine production by T cells from 223 the lungs of infected CC042 mice may indicated that there is an impairment in either T cell priming 224 or recruitment of T cells to the lung. 225
In order to distinguish between these possibilities, we counted the number of CD4 and CD8 T cells 227 in the lung, mediastinal lymph node (mLN) and spleen at 28 days post infection using flow 228 cytometry. At the same time, we enumerated the number of antigen specific CD4 and CD8 T cells 229 using ESAT-6 (CD4) and TB10.4 (CD8) tetramers. CC042 mice had fewer total CD4 and CD8 T 230 cells in the lung compared to B6 mice ( Fig 6C) . This was also true in the mLN but not the spleen 231
( Fig 6D, E) . While we saw that CC042 mice had significantly fewer ESAT-6-specific CD4 and 232 TB10.4-specific CD8 T cells in the lung than B6 animals, both groups of mice had similar numbers 233 of antigen-specific T cells in the mLN and the spleen (Fig 6 F, G, H) . When antigen-specific T cells 234
were considered as a fraction of total T cells, the frequencies of ESAT-6-specific T cells was similar 235 in the lung, spleen and mLN of B6 and CC042 mice, while the frequency of TB10.4-specific T cells 236 were lower in the lungs of CC042 mice but were higher in the spleen and mLN in comparison to B6 237 mice (Supp Fig 3) . Taken together, this suggests that T cell priming of Mtb-specific CD4 and CD8 T 238 cells was occurring in the draining LN, and the diminished T cell numbers in the lungs of CC042 239 mice is due to an impairment in T cell recruitment. As such, we examined the cell surface expression 240 of CD44, CD69, CD62L and CD11a on CD4 and CD8 T cells from the lungs of infected CC042 241 and B6 mice, as these markers have been classically associated with either T cell activation or 242 migration (41, 42). We found that CD4 and CD8 T cells from the lungs of CC042 and B6 mice had 243 appropriately upregulated CD44 and CD69 and downregulated CD62L ( Fig 6I) . However, CD11a 244 was undetectable on both CD4 and CD8 T cells from CC042 mice. As CD11a is the aL component 245 of aLb2, the principal β2-integrin on T cells that is crucial for lymphocyte trafficking, this defect 246 could explain many of the immunological differences observed between CC042 and B6. 247 248 A CC042 private mutation in Itgal explains The gene encoding CD11a, Itgal, is located on chromosome 7, within the Tip2 locus identified in our 250
intercross. The lack of CD11a expression on CC042 lymphocytes implicated Itgal variation as the 251 basis for Tip2. To investigate this possibility, CD11a expression was assayed in WSB and CC011 252 strains, which contain the susceptibility-associated WSB haplotype at Tip2 (Fig 7a) . We found that 253 WSB and CC011 splenocytes expressed similar CD11a levels as B6 mice, leading us to hypothesize 254 that CC042 had incurred a private mutation during inbreeding that impacts CD11a production. 255
256
Using whole genome sequences of representative CC strains, variants private to each have been 257 identified (43, 47) . Using this dataset, we found that the CC042 genome sequence contains a 15 bp 258 deletion in the first intron of the Itgal1 gene, which is not present in the ancestral WSB allele. This 259 deletion alters the canonical splice acceptor sequence ("AG") at the 3' terminus of intron 1 260 (http://Jul2019.archive.ensembl.org/Mus_musculus_WSB_EiJ/Transcript/Exons?db=core;g=MG 261 P_WSBEiJ_G0032170;r=7:131372531-131430694;t=MGP_WSBEiJ_T0085398). Although the 262 resultant mutant sequence ("TG") has been observed to function as a splice acceptor in certain 263 transcripts (43), we hypothesized that this mutation could alter splicing. Amplification and 264 sequencing of a fragment spanning exons 1 and 3 of the Itgal mRNA confirmed that the CC042 265 transcript lacked the exon 2 sequence that was contained in both the B6 and WSB mRNAs (Fig.  266   7B) . The lack of exon 2 is predicted to produce a frameshift and premature termination (Fig. 7B) . 267
While Tip2 was only significantly associated with spleen CFU and lung IFNg in the whole genome 268 scans, the lack of T cells in the lungs of CC042 animals suggested the CD11a deficiency also 269 influenced bacterial replication at this site. To test this hypothesis, we used the measured 270 phenotypes from the F2 cross and found that the CC042 Itgal allele was significantly associated with 271 higher CFU values (Fig7 C-E). This analysis indicated that the Itgal mutation affects all metrics of 272 tuberculosis susceptibility in CC042. 273 274
Discussion: 275
In this work, we used a classic genetic strategy to investigate the diversity of responses to Mtb 276 infection observed in CC strains. Previous work identified a number of genetically-dissociable 277 immunophenotypes in Mtb-infected CC founder lines, including bacterial load and IFNg production 278 (37). The intercross between two phenotypically divergent CC strains reported here supports the 279 independence of these traits and demonstrates that multiple phenotypes can be mapped 280 simultaneously using this strategy. Investigating the genetic architecture of TB disease in these 281
highly diverse mice revealed a number of new insights that would not have been apparent in 282 intercrosses between more genetically-homogenous lab strains. 283
284
A loss-of-function mutation in Itgal was found to account for the Tip2 QTL and explain a significant 285 portion of the susceptibility of the CC042 line. We previously found that Itgal deletion in the B6 286 background resulted in a defect in T cell recruitment to the lung and increased pulmonary Mtb 287 burden (44), both traits that are associated with Itgal-deficiency in the CC001xCC042 intercross. 288
While Tip2 was only significantly associated with spleen CFU and IFNg production in whole 289 genome scans, Itgal genotype also correlated with lung CFU when examined in isolation. Thus, we 290 conclude that Itgal affects pathogenesis in both lung and spleen, and the lack of genome wide 291 association between Itgal and lung CFU is likely due to complex genetic factors, such as the observed 292 overdominance and the possible presence of additional variants that dilute the effect of the Itgal 293
mutation. 294
While the disease-promoting effect of CD11a deficiency was generally consistent between the B6 296 background and the recombinant CC genotype, the loss of Itgal is insufficient to explain the 297 susceptibility of the CC042 strain. These CC042 mice succumb to infection approximately five 298 months earlier than Itgal -/-B6 mice (44), likely due to the more dramatic infiltration of granulocytes 299 and necrosis observed in the lung. The increased susceptibility of CC042 animals can be attributed, 300
at least in part, to Tip1. The variant(s) underlying Tip1 appear to be functionally distinct from Itgal, 301
as the effect of Tip1 and Tip2 are additive, these traits differ in their mode of inheritance, and Tip1 is 302 not associated with IFNg levels. These data indicate that IFNg-independent mechanisms, such as 303 those underlying Tip1, can act in an additive fashion to increase the susceptibility of animals with a 304 more canonical immunodeficiency that affects Th1 cell activity. 305
306
This intercross between two very diverse genotypes allowed the mapping of QTL that may be 307 associated with an additional trait previously identified in the CAST founder strain. Despite being 308 relatively resistant to Mtb infection, CAST mice do not produce detectable levels of IFNg in the 309 lung (37). This observation is one of many indicating that IFNg-independent immune mechanisms 310 play an important protective role, particularly in the lungs (38, 45, 46) . Tip1, and Tip3, are likely 311 related to the IFNg-deficient phenotype of CAST mice. This founder haplotype at Tip3 is associated 312 with low IFNg production, and the CAST allele at Tip1 reduces CFU without influencing IFNg 313 levels. Defining the basis of this phenotype, might represent an important step to understanding the 314 immune response to Mtb in the recently identified subset of humans that control Mtb infection in 315 the absence of a detectable IFNg response (23). 316
The CC population was initially envisioned as a genetic mapping resource, based on the random 318 distribution of founder alleles between strains (47). While the CC panel been shown to be valuable 319 for this type of study, the Itgal mutation identified in this work was not derived from a founder line 320 and likely occurred during the process of inbreeding CC042. Such mutations in individual CC 321 strains provide an additional advantage to studies within the CC: both common variants, as well as 322 private variants (~28,000) circulate in this population and can drive disease responses (39, 48) . While 323 these mutations are invisible in genetic association studies that are based on comparison of CC lines, 324 our work shows that their effect can be revealed through intercrosses and the molecular 325 characterization of these relatively rare variants can be rapidly achieved. This feature, in 326 combination with the variety of phenotypes that can be addressed in CCxCC intercrosses, highlight 327 the value of this approach. 328
329
The immune response to Mtb in natural populations is variable. Several lines of recent evidence 330 suggest the importance of mechanisms distinct from canonical Th1 immunity that dominate in the 331 classic "mouse model" of TB, which relies on a small number of genetically similar mouse lines. 332
Using a simple intercross strategy, we leveraged the genetic diversity of CC lines to define 333 chromosomal loci controlling three distinct TB-related traits; Itgal-dependent T cell recruitment 334 (Tip2), IFNg-independent bacterial control (Tip1), and IFNg production (Tip3-4). All of these traits 335 associated with haplotypes that are absent from standard mouse strains, supporting the value of 336 genetic diversity to understand highly variable traits, such as TB susceptibility. 337 338
Materials and Methods: 339
Ethics statements and experimental animals: 340 C57BL/6J (#0664) (B6) mice were purchased from the Jackson labs. CC042/GeniUnc and 341 CC001/Unc mice were obtained from the Systems Genetics Core Facility at the University of North 342
Carolina (49), and bred at UMASS Medical School under specific pathogen-free conditions and in 343 accordance with the University of Massachusetts Medical School IACUC guidelines. F1 mice were 344 generated from crossing CC001 females by CC042 males (CC001xCC042). The F2 mice used for 345 QTL mapping were obtained from crossing these F1 mice (e.g. all F2 animals were 346 
CFU enumeration and cytokine quantification 360
To determine CFU, mice were anesthetized via inhalation with isoflurane (Piramal) and euthanized 361 via cervical dislocation. The organs were aseptically removed and individually homogenized, and 362 viable bacteria enumerated by plating 10-fold serial dilutions onto 7H10 agar plates. Plates were 363 incubated at 37°C, and colonies were counted after 21 days. Cytokine concentrations in cell-free 364 lung homogenates were quantified using commercial enzyme-linked immunosorbent assay (ELISA) 365 kits (IFNg Duo Set #DY485 R&D Systems) according to manufacturer instructions. 366 367
Histology: 368
Lung lobes from B6 and CC042 mice infected with Mtb were fixed in 10% neutral buffered 369 formalin, embedded in paraffin, and sectioned at 5µm. Sections were stained with hematoxylin and 370 eosin (H&E). All sectioning and staining was done by the Diabetes and Endocrinology Research 371
Center Morphology Core (DERC) at the University of Massachusetts Medical School. Images were 372 captured on a TissueGnostics TissueFAXS PLUS at 2X and 20X magnification. 373 374
Flow cytometry analysis: 375
Lung tissue was harvested in RPMI containing FBS and placed in C-tubes (Miltenyi). Collagenase 376 type IV/DNase I was added and tissues were dissociated for 10 seconds on a GentleMACS system 377 (Miltenyi). Tissues were incubated for 30 minutes at 37°C with oscillations and then dissociated for 378 an additional 30 seconds on a GentleMACS. Lung homogenates were passed through a 70-micron 379 filter. Cell suspensions were washed in RPMI, passed through a 40-micron filter and aliquoted into 380 96 well plates for flow cytometry staining. Non-specific antibody binding was first blocked using Fc-381
Block, after which cells were then stained with CD3-BV785 (145-2CL1), CD8-APC-Fire 750 (53-382 8.7), CD44-PerCP-Cy5.5 (IM7), CD11a-BV711 (M17/4), CD69-PE-Cy7 (H1.2F3) and CD62L-383 BV570 (MEL-14) from Biolegend and CD4-Alexa Fluor 700 (RM4-5) from BD Biosciences. In 384 some experiments, intracellular cytokine staining was also performed. After surface marker staining, 385 cells were subsequently permeabilized using cytofix/cytoperm (BD Biosciences) and stained with 386 IFN-APC (XMG1.2), IL-2 PE-Cy7(JES6-5H4), IL-17a-BV650 (TC11-18H10.1), TNF-BV421 387 (MP6-XT22), IL-10 (JES5-16E3) and CD107a-PE (1D4B) from Biolegend and IL-4-Alexa Fluor 388 488 (11B11) from Invitrogen. Live cells were identified using fixable live dead aqua (Life 389 Technologies). Cells were stained for 30 minutes at room temperature and fixed in 1% 390
Paraformaldehyde for 60 minutes. All flow cytometry was run on either a MACSQuant Analyzer 10 391 (Miltenyi) or Aurora (Cytek) and was analyzed using FlowJo_V10 (Tree Star). 392
393
Genotyping and QTL mapping: 394 1500 nanograms of DNA was genotyped by Neogen Inc. using the the MiniMuga array. We filtered 395 markers to those that were consistent within a previously published set of CC042 and CC001 396 genotypes (39), and diagnostic between these strains (i.e., CC001 genotype ≠ CC042 genotype and F1 397 genotype called heterozygous). After finding and removing misplaced markers, identified using the 398 droponemarker function of the R package qtl (R/qtl), regions of dense marker coverage were 399 thinned to a spacing of 0.1 cM. The final genetic map contained 1806 markers. 400 401 Genotype and phenotype data were imported into R (version 3.4.3) and reformatted for R/qtl 402 (version 1.42-8). Genotype probabilities were calculated at 0.25 cM spacing, and QTL mapping was 403 carried out using the scanone function using batch and sex as additive covariates. Significant LOD 404 thresholds were established by permutation test with 10,000 permutation replicates. Multi-QTL 405 models were fit using R/qtl's fitqtl function. LOD profiles and effect plots were generated using the 406 plotting functions of the R/qtl package. 407 408
Ex vivo RNA isolation and qRT-PCR 409
Bone marrow derived macrophages (BMDMs) from C57BL/6J, WSB/EiJ and CC042 mice were 410 generated. Briefly, marrow from femurs and tibia of age-and sex-matched mice was isolated and 411 cultured in high glucose DMEM (Gibco 11965092) supplemented with L-glutamine, 10% fetal 412 bovine serum (FBS, Sigma F4135), and 20% L929 conditioned media. After seven days, 413 differentiated cells were lifted with PBS with 10mM EDTA and seeded for subsequent 414 experimentation. RNA was isolated by lysing the cells in Trizol (ThermoFisher 15596018) were infected in one batch and 3 males and 3 females for each strain were used for analysis at each 457 time point. Graphs represent mean ± SD. One-way ANOVA with Sidak's multiple comparisons test 458 was used to determine significance, where p<0.05 *, p<0.01**, p<0.001***, and p<0.0001****. monocytes/macrophages (lymphocytes > single cells > Gr1-CD11b+). All mice were infected in 484 one batch and 3 males and 3 females for each strain used for analysis at each time point. Graphs 485 represent mean ± SD. One-way ANOVA with Sidak's multiple comparisons test was used to 486 determine significance where p<0.05 *, p<0.01**, p<0.001***, and p<0.0001****. 
499
Histograms depicting CD11a staining in CD4 (left) and CD8 (right) T cells from B6 (gray shading), 500 WSB (purple shading), CC011 (light blue shading), and CC042 (teal shading). The isotype control 501 antibody staining is shown on each plot as a dotted gray trace. (B). PCR primers flanking the 502 putative private Itgal mutation were used to amplify cDNA from B6, WSB, and CC042 RNA. PCR 503 products were separated by gel electrophoresis on a 3% agarose gel. Lanes 2 and 3 show the 197bp 504 amplicons for B6 and WSB, the parental allele for CC042. The 100bp size decrease in the CC042-505 derived product is consistent the loss of exon 2 (lane 4 and schematic). Sanger sequencing traces 506 from the CC042 and WSB amplicons are shown. TB immunophenotypes were reevaluated in F2 507 progeny of the CC001xCC042 that were homozygous for each parental allele at the Itgal locus 508 (probe UNC13811649): (C) Lung CFU, spleen (D) CFU, and (E) lung IFNg levels Welch's t-test 509 was used to determine significance where p<0.05 *, p<0.01**, p<0.001***, and p<0.0001****. Box 510 and whiskers plots indicate the median and min to max values. 511 512 
